RecruitingNCT05890183
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
In Los AngelesSchizophreniaBehavioural studyAges 18–45
Study directory
Back to overviewSchizophrenia studies
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
RecruitingNCT07192042
Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized people with Schizophrenia
Official study title
In New Taipei CityInvestigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia
SchizophreniaObservational studyAges 20–70
RecruitingNCT06672588
Magnetic Seizure Therapy for Schizophrenia - study
Official study title
Multiple locations, including VancouverMagnetic Seizure Therapy for Schizophrenia - Trial
SchizophreniaDevice studyAges 18+
RecruitingNCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Official study title
In PhiladelphiaEffect of Varenicline on Smoking Cessation in Patients With Schizophrenia: Evaluation of Antipsychotic Drug-Induced Neurological Symptoms as Correlates of Response
SchizophreniaMedication studyAges 18–75
RecruitingNCT02639702
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
Official study title
In TorontoSwitching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia: A Pilot, Double-Blind, Randomized Controlled Trial
SchizophreniaMedication studyAges 18+
RecruitingNCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Official study title
In BatlimoreA Double-Blind Placebo-Controlled Trial of the Synbiotic Compound Probio-Tec ABCG for Schizophrenia Patients With and Without Elevated Markers of Gastrointestinal Inflammation
SchizophreniaPlacebo comparisonAges 18–65
RecruitingNCT07058389
Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
Official study title
In Saint-EtienneSynergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia: a Pilot Study.
SchizophreniaInterventional studyAges 18–55
Not Yet RecruitingNCT07445620
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms for schizophrenia
Official study title
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia: DB-RCT
This study isn't recruiting yet.
In BhubaneswarSchizophreniaDevice studyAges 18–60
RecruitingNCT06911931
Visual Perception in Schizophrenia
Official study title
In RochesterVisual Perception in Schizophrenia: Assessing Predictive Processing in the Earliest Stages of the Visual Cortical Hierarchy
Schizophrenia, BipolarityInterventional studyAges 18–65
RecruitingNCT06740383
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Multiple locations, including HartfordSchizophrenia, BipolarityObservational studyAges 18–40
RecruitingNCT07441928
Effects of Smoking on Network Connectivity in people with Schizophrenia Symptoms in Scz Patients
Official study title
In Hong KongUsing Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Acceptance and Commitment Therapy for Smoking Cessation and Reduction of Psychotic Symptoms in Patients With Schizophrenia
SchizophreniaInterventional studyAges 18+
RecruitingNCT06191965
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Official study title
In BelmontDouble Blind, Randomized, Placebo-Controlled Study of MitoQ as Adjunctive Treatment for Patients With Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
SchizophreniaMedication studyAges 18–35
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.